U.S. Pharmaceuticals & Biotech Most Popular Stocks

Eli Lilly

Market Cap: US$920.0b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Johnson & Johnson

Market Cap: US$509.8b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

AbbVie

Market Cap: US$394.7b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

Merck

Market Cap: US$248.9b

Operates as a healthcare company worldwide.

Thermo Fisher Scientific

Market Cap: US$215.0b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

Amgen

Market Cap: US$171.1b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Danaher

Market Cap: US$159.9b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

Gilead Sciences

Market Cap: US$149.4b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Pfizer

Market Cap: US$147.0b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Vertex Pharmaceuticals

Market Cap: US$114.7b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

Bristol-Myers Squibb

Market Cap: US$106.7b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Regeneron Pharmaceuticals

Market Cap: US$76.1b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Alnylam Pharmaceuticals

Market Cap: US$52.5b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

Zoetis

Market Cap: US$52.3b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

Insmed

Market Cap: US$42.0b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Agilent Technologies

Market Cap: US$39.5b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

IQVIA Holdings

Market Cap: US$37.9b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

BeOne Medicines

Market Cap: US$35.3b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Teva Pharmaceutical Industries

Market Cap: US$34.2b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Natera

Market Cap: US$32.0b

A diagnostics company, provides molecular testing services worldwide.

Mettler-Toledo International

Market Cap: US$28.5b

Manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.

Biogen

Market Cap: US$25.5b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Waters

Market Cap: US$22.9b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

BioNTech

Market Cap: US$22.8b

A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.

Royalty Pharma

Market Cap: US$22.2b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

United Therapeutics

Market Cap: US$21.3b

A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Illumina

Market Cap: US$20.6b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Exact Sciences

Market Cap: US$19.3b

Provides cancer screening and diagnostic test products in the United States and internationally.

West Pharmaceutical Services

Market Cap: US$19.2b

Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Incyte

Market Cap: US$18.7b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Medpace Holdings

Market Cap: US$15.7b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Roivant Sciences

Market Cap: US$15.4b

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.

Revolution Medicines

Market Cap: US$15.3b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Neurocrine Biosciences

Market Cap: US$15.2b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

BridgeBio Pharma

Market Cap: US$14.5b

A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

ICON

Market Cap: US$14.2b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.